| Ms Tayler Stanley, MA CCC-SLP | |
|
1380 Southern Ave Se, Washington, DC 20032-4623 | |
| (202) 561-5952 | |
| Not Available |
| Full Name | Ms Tayler Stanley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1380 Southern Ave Se, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295109411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP000891 (District Of Columbia) | Primary |
| 235Z00000X | Speech-language Pathologist | 2202007586 (Virginia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Tayler Stanley, MA CCC-SLP 1475 N Highview Ln, Apt 411, Alexandria, VA 22311-2314 Ph: (814) 594-5025 | Ms Tayler Stanley, MA CCC-SLP 1380 Southern Ave Se, Washington, DC 20032-4623 Ph: (202) 561-5952 |
News Archive
The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States.
New research has failed to confirm findings from smaller studies that 85 gene variations are associated with an increased risk for acute coronary syndromes (ACS), which includes heart attack and a type of angina, according to a study in the April 11 issue of JAMA.
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Researchers at Wake Forest University Baptist Medical Center are preparing to begin a clinical trial aimed at testing an investigational new drug that may help control the progression of Alzheimer's disease.
› Verified 7 days ago
Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424 | |
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324 | |
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559 | |
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404 | |
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641 | |
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469 | |
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840 |